CH BIOTECH SER (08037): The boron neutron therapy device successfully achieved its first beam output.

CH BIOTECH SER (08037) announced that the flagship project of the group, Pengbo (Hainan) Boron Neutron Hospital, located in the Bo'ao Lecheng International Medical Tourism Pioneer Zone in Hainan, made significant progress on November 20, 2025. The neutron irradiation system of the core device NeuCure for boron neutron capture therapy (boron neutron therapy) in the hospital has successfully achieved its first beam output and has officially entered the final clinical trial phase, marking an important milestone in the project's progress and laying a solid foundation for the hospital's future operation. With the support of the policies in the Bo'ao Lecheng International Medical Tourism Pioneer Zone in Hainan, this system is currently the only boron neutron therapy system in the world that has obtained official medical device registration and can be directly applied to routine clinical treatment (not in the clinical trial stage). Clinical treatment services are expected to officially begin in the first quarter of 2026. The successful beam output this time validates that all parameters of the system's core components meet the design requirements, signaling the official transition of the project from equipment installation to beamline commissioning. This key milestone achievement lays a solid foundation for subsequent core tasks such as precise control of neutron dose rate, beam physics verification, and biological effect evaluation, ensuring that the equipment can advance clinical treatment according to the planned high standards, providing safe and precise boron neutron therapy services for cancer patients.